Citation

Lansdowne K, Scully CG, Galeotti L, Schwartz S, Marcozzi D, Strauss DG. Prehosp. Disaster Med. 2015; 30(3): 320-323.

Affiliation

1Center for Devices and Radiological Health,US Food and Drug Administration,Silver Spring,Maryland,USA.

Copyright

(Copyright © 2015, Cambridge University Press)

DOI

10.1017/S1049023X15004641

PMID

25868677

Abstract

In 2010, the US Food and Drug Administration (Silver Spring, Maryland USA) created the Medical Countermeasures Initiative with the mission of development and promoting medical countermeasures that would be needed to protect the nation from identified, high-priority chemical, biological, radiological, or nuclear (CBRN) threats and emerging infectious diseases. The aim of this review was to promote regulatory science research of medical devices and to analyze how the devices can be employed in different CBRN scenarios. Triage in CBRN scenarios presents unique challenges for first responders because the effects of CBRN agents and the clinical presentations of casualties at each triage stage can vary. The uniqueness of a CBRN event can render standard patient monitoring medical device and conventional triage algorithms ineffective. Despite the challenges, there have been recent advances in CBRN triage technology that include: novel technologies; mobile medical applications ("medical apps") for CBRN disasters; electronic triage tags, such as eTriage; diagnostic field devices, such as the Joint Biological Agent Identification System; and decision support systems, such as the Chemical Hazards Emergency Medical Management Intelligent Syndromes Tool (CHEMM-IST). Further research and medical device validation can help to advance prehospital triage technology for CBRN events. Lansdowne K , Scully CG , Galeotti L , Schwartz S , Marcozzi D , Strauss DG. Recent advances in medical device triage technologies for chemical, biological, radiological, and nuclear events. Prehosp Disaster Med. 2015;30(3):1-4.

Language: en